Same Indication

Pembrolizumab vs Sumatriptan

Pembrolizumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Sumatriptan.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Sumatriptan: Selective 5-HT1B/1D receptor agonist.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Sumatriptan — 2.5 hours.

Chemical Properties

Molecular Formula: Sumatriptan — C14H21N3O2S.

Molecular Weight: Sumatriptan — 295.4020 g/mol.

Type: Pembrolizumab — Antibody; Sumatriptan — Small molecule.